Efficacy  	Efficacy  	 NNP	O
of  	of  	 IN	O
single-dose  	single-dose  	 JJ	B-NP
intravenous  	intravenous  	 JJ	I-NP
phenylbutazone  	phenylbutazone  	 NN	I-NP
and  	and  	 CC	O
flunixin  	flunixin  	 JJ	B-NP
meglumine  	meglumine  	 NNS	I-NP
before 	before 	 RB	O
,  	,  	 ,	O
during  	during  	 IN	O
and  	and  	 CC	O
after  	after  	 IN	O
exercise  	exercise  	 NN	O
in  	in  	 IN	O
an  	an  	 DT	O
experimental  	experimental  	 JJ	B-NP
reversible  	reversible  	 JJ	I-NP
model  	model  	 NN	I-NP
of  	of  	 IN	O
foot  	foot  	 NN	O
lameness  	lameness  	 NN	O
in  	in  	 IN	O
horses  	horses  	 FW	B-NP
Objective  	Objective  	 FW	I-NP
blinded  	blinded  	 FW	O
efficacy  	efficacy  	 FW	O
data  	data  	 NNS	O
during  	during  	 IN	O
exercise  	exercise  	 NN	O
are  	are  	 VBP	O
lacking  	lacking  	 VBG	O
on  	on  	 IN	O
the  	the  	 DT	O
use  	use  	 NN	O
of  	of  	 IN	O
single-dose  	single-dose  	 JJ	B-NP
i.v.  	i.v.  	 CD	I-NP
nonsteroidal  	nonsteroidal  	 CD	O
anti-inflammatory  	anti-inflammatory  	 JJ	O
drugs  	drugs  	 NNS	O
( 	( 	 -LRB-	O
NSAIDs 	NSAIDs 	 NNP	B-NP
)  	)  	 -RRB-	O
before 	before 	 RB	O
,  	,  	 ,	O
during  	during  	 IN	O
and  	and  	 CC	O
after  	after  	 IN	O
exercise 	exercise 	 NN	O
.  	.  	 .	O
Single  	Single  	 JJ	B-NP
i.v.  	i.v.  	 CD	I-NP
doses  	doses  	 NNS	O
of  	of  	 IN	O
either  	either  	 DT	O
phenylbutazone  	phenylbutazone  	 NN	B-NP
( 	( 	 -LRB-	O
PBZ 	PBZ 	 NNP	B-NP
)  	)  	 -RRB-	O
or  	or  	 CC	O
flunixin  	flunixin  	 JJ	B-NP
meglumine  	meglumine  	 NNS	I-NP
( 	( 	 -LRB-	O
FM 	FM 	 NNP	B-NP
)  	)  	 -RRB-	O
would  	would  	 MD	O
prove  	prove  	 VB	O
more  	more  	 JJR	O
efficacious  	efficacious  	 NN	O
than  	than  	 IN	O
negative  	negative  	 JJ	B-NP
saline  	saline  	 JJ	I-NP
control  	control  	 NN	I-NP
( 	( 	 -LRB-	O
SAL 	SAL 	 NNP	B-NP
)  	)  	 -RRB-	O
before 	before 	 RB	O
,  	,  	 ,	O
during  	during  	 IN	O
and  	and  	 CC	O
after  	after  	 IN	O
exercise  	exercise  	 NN	O
in  	in  	 IN	O
a  	a  	 DT	O
reversible  	reversible  	 JJ	O
model  	model  	 NN	O
of  	of  	 IN	O
foot  	foot  	 NN	O
lameness 	lameness 	 NN	O
.  	.  	 .	O
Six  	Six  	 CD	O
Quarter  	Quarter  	 NNP	O
Horse  	Horse  	 NNP	O
mares  	mares  	 NN	O
had  	had  	 VBD	O
lameness  	lameness  	 JJ	O
induced  	induced  	 NN	O
by  	by  	 IN	O
tightening  	tightening  	 VBG	O
a  	a  	 DT	O
set  	set  	 NN	B-NP
screw  	screw  	 NN	I-NP
against  	against  	 IN	O
a  	a  	 DT	O
heart  	heart  	 NN	B-NP
bar  	bar  	 NN	I-NP
shoe  	shoe  	 NN	I-NP
1  	1  	 CD	O
h  	h  	 NNS	B-NP
prior  	prior  	 RB	I-NP
to  	to  	 TO	O
treatment 	treatment 	 NN	O
.  	.  	 .	O
Randomised  	Randomised  	 JJ	B-NP
blinded  	blinded  	 JJ	I-NP
treatments  	treatments  	 NNS	I-NP
included  	included  	 VBD	I-NP
PBZ  	PBZ  	 NNP	I-NP
( 	( 	 -LRB-	O
4.4  	4.4  	 FW	O
mg 	mg 	 FW	B-NP
/ 	/ 	 FW	I-NP
kg  	kg  	 FW	I-NP
bwt  	bwt  	 FW	I-NP
i.v. 	i.v. 	 FW	I-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
FM  	FM  	 NNP	B-NP
( 	( 	 -LRB-	O
1.1  	1.1  	 FW	O
mg 	mg 	 FW	B-NP
/ 	/ 	 FW	I-NP
kg  	kg  	 FW	I-NP
bwt  	bwt  	 FW	I-NP
i.v. 	i.v. 	 FW	I-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
SAL  	SAL  	 NNP	B-NP
( 	( 	 -LRB-	O
1  	1  	 CD	O
ml 	ml 	 CD	O
/ 	/ 	 CD	O
45  	45  	 CD	O
kg  	kg  	 CD	B-NP
i.v. 	i.v. 	 CD	I-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Heart  	Heart  	 NN	B-NP
rate  	rate  	 NN	I-NP
and  	and  	 CC	O
lameness  	lameness  	 JJ	B-NP
score  	score  	 NN	I-NP
( 	( 	 -LRB-	O
LS 	LS 	 NNP	B-NP
)  	)  	 -RRB-	O
were  	were  	 VBD	O
recorded  	recorded  	 VBN	O
at  	at  	 IN	O
rest 	rest 	 NN	O
;  	;  	 :	O
every  	every  	 DT	O
20  	20  	 CD	O
min  	min  	 NN	B-NP
after  	after  	 IN	O
lameness  	lameness  	 JJ	B-NP
induction  	induction  	 NN	I-NP
for  	for  	 IN	O
5  	5  	 CD	O
h  	h  	 NNS	O
and  	and  	 CC	O
at  	at  	 IN	O
the  	the  	 DT	O
end  	end  	 NN	O
of  	of  	 IN	O
2  	2  	 CD	O
min  	min  	 NNS	B-NP
treadmill  	treadmill  	 VBP	I-NP
workloads  	workloads  	 VBN	I-NP
of  	of  	 IN	O
2  	2  	 CD	O
and  	and  	 CC	O
4  	4  	 CD	O
m 	m 	 CD	B-NP
/ 	/ 	 CD	I-NP
s 	s 	 NNS	I-NP
.  	.  	 .	O
Heart  	Heart  	 NN	B-NP
rate  	rate  	 NN	I-NP
was  	was  	 VBD	O
also  	also  	 RB	O
recorded  	recorded  	 VBN	O
from  	from  	 IN	O
0.5-60  	0.5-60  	 CD	O
min  	min  	 JJ	B-NP
post  	post  	 NN	I-NP
exercise 	exercise 	 NN	I-NP
.  	.  	 .	O
Results  	Results  	 NNS	O
were  	were  	 VBD	O
compared  	compared  	 VBN	O
using  	using  	 VBG	O
RM  	RM  	 NNP	B-NP
ANOVA  	ANOVA  	 NNP	I-NP
and  	and  	 CC	O
Student-Newman-Keul 	Student-Newman-Keul 	 NNP	O
's  	's  	 POS	O
test  	test  	 NN	O
( 	( 	 -LRB-	O
HR 	HR 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
Wilcoxon  	Wilcoxon  	 NNP	O
signed  	signed  	 VBD	O
rank  	rank  	 JJ	O
test  	test  	 NN	O
( 	( 	 -LRB-	O
% 	% 	 NN	O
ΔLS 	ΔLS 	 NNP	B-NP
)  	)  	 -RRB-	O
with  	with  	 IN	O
significance  	significance  	 NN	B-NP
set  	set  	 VBN	O
at  	at  	 IN	O
P  	P  	 NN	O
< 	< 	 SYM	O
0.05 	0.05 	 CD	O
.  	.  	 .	O
Pre-exercise  	Pre-exercise  	 JJ	B-NP
mean  	mean  	 JJ	O
HR  	HR  	 NNP	B-NP
was  	was  	 VBD	O
decreased  	decreased  	 VBN	O
for  	for  	 IN	O
both  	both  	 DT	O
NSAIDs  	NSAIDs  	 JJ	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
SAL  	SAL  	 NNP	B-NP
from  	from  	 IN	O
1 	1 	 CD	O
: 	: 	 :	O
20-4  	20-4  	 CD	O
h  	h  	 JJ	B-NP
post  	post  	 NN	I-NP
treatment  	treatment  	 NN	I-NP
( 	( 	 -LRB-	O
P  	P  	 NNP	O
< 	< 	 SYM	O
0.05 	0.05 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Pre-exercise  	Pre-exercise  	 JJ	B-NP
mean  	mean  	 JJ	O
% 	% 	 NN	O
ΔLS  	ΔLS  	 NNP	B-NP
was  	was  	 VBD	O
decreased  	decreased  	 VBN	O
for  	for  	 IN	O
PBZ  	PBZ  	 NNP	B-NP
( 	( 	 -LRB-	O
1 	1 	 LS	O
: 	: 	 :	O
20-4  	20-4  	 CD	O
h 	h 	 CD	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
FM  	FM  	 NNP	B-NP
( 	( 	 -LRB-	O
1-4  	1-4  	 FW	O
h 	h 	 FW	O
)  	)  	 -RRB-	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
SAL  	SAL  	 NNP	B-NP
( 	( 	 -LRB-	O
P  	P  	 NNP	O
< 	< 	 SYM	O
0.01 	0.01 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
With  	With  	 IN	O
exercise 	exercise 	 NN	O
,  	,  	 ,	O
there  	there  	 EX	O
were  	were  	 VBD	O
no  	no  	 DT	O
HR  	HR  	 NNP	B-NP
differences  	differences  	 NNS	I-NP
between  	between  	 IN	O
treatments  	treatments  	 NNS	O
( 	( 	 -LRB-	O
P  	P  	 NNP	O
>  	>  	 CD	O
0.05 	0.05 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
but  	but  	 CC	O
mean  	mean  	 JJ	O
% 	% 	 NN	O
ΔLS  	ΔLS  	 NNP	B-NP
was  	was  	 VBD	O
decreased  	decreased  	 VBN	O
for  	for  	 IN	O
both  	both  	 DT	O
NSAIDs  	NSAIDs  	 JJ	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
SAL  	SAL  	 NNP	B-NP
( 	( 	 -LRB-	O
P  	P  	 NNP	O
< 	< 	 SYM	O
0.01 	0.01 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Mean  	Mean  	 JJ	B-NP
recovery  	recovery  	 NN	I-NP
HR  	HR  	 NNP	I-NP
was  	was  	 VBD	O
decreased  	decreased  	 VBN	O
for  	for  	 IN	O
PBZ  	PBZ  	 NNP	B-NP
and  	and  	 CC	O
FM  	FM  	 NNP	B-NP
from  	from  	 IN	O
1-60  	1-60  	 NNP	O
min  	min  	 VBD	B-NP
compared  	compared  	 VBN	O
to  	to  	 TO	O
SAL  	SAL  	 NNP	B-NP
( 	( 	 -LRB-	O
P  	P  	 NNP	O
< 	< 	 SYM	O
0.05 	0.05 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
PBZ  	PBZ  	 NNP	B-NP
and  	and  	 CC	O
FM  	FM  	 NNP	B-NP
demonstrated  	demonstrated  	 VBD	O
definitive  	definitive  	 JJ	O
clinical  	clinical  	 JJ	B-NP
efficacy  	efficacy  	 NN	I-NP
after  	after  	 IN	O
single  	single  	 JJ	O
i.v.  	i.v.  	 CD	B-NP
doses  	doses  	 NNS	O
before 	before 	 RB	O
,  	,  	 ,	O
during  	during  	 IN	O
and  	and  	 CC	O
after  	after  	 IN	O
exercise 	exercise 	 NN	O
.  	.  	 .	O
Use  	Use  	 NN	O
of  	of  	 IN	O
single  	single  	 JJ	O
i.v.  	i.v.  	 CD	B-NP
doses  	doses  	 NNS	O
during  	during  	 IN	O
competition  	competition  	 NN	O
may  	may  	 MD	O
mask  	mask  	 VB	O
lameness  	lameness  	 NNS	O
and  	and  	 CC	O
may  	may  	 MD	O
affect  	affect  	 VB	O
the  	the  	 DT	O
ability  	ability  	 NN	B-NP
of  	of  	 IN	O
judges  	judges  	 NNS	O
in  	in  	 IN	O
determining  	determining  	 VBG	O
the  	the  	 DT	O
soundness  	soundness  	 NN	O
of  	of  	 IN	O
horses  	horses  	 NNS	O
in  	in  	 IN	O
competition 	competition 	 NN	O
.  	.  	 .	O
